✦ LIBER ✦

The genotyping of UGT1A1 polymorphism for the dose adjustment of irinotecan in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab as the first-line regimen

✍ Scribed by Lu, Chien-Yu; Tsai, Hsiang-Lin; Wang, Jaw-Yuan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

710: Clinical implication of UGT1A1 prom

✍ Wang, J.; Lu, C.Y. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 66 KB

UGT1A1 genotyping for irinotecan-based c

✍ Yeh, Yung-Sung; Wu, Ming-Xia; Huang, Meng-Lin; Chang, Se-Fen; Chen, Chin-Fan; Hu 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 185 KB

Prognostic advantage of irinotecan dose

✍ Lu, Chien-Yu; Huang, Ching-Wen; Hu, Huang-Ming; Tsai, Hsiang-Lin; Huang, Chun-Mi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 455 KB

Bevacizumab plus irinotecan, 5-fluoroura

✍ Deng, Ting; Zhang, Le; Liu, Xiao-jian; Xu, Jian-ming; Bai, Yu-xian; Wang, Yan; H 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 199 KB

Predictors of the efficacy of FOLFIRI pl

✍ Mitsukuni Suenaga; Satoshi Matsusaka; Masashi Ueno; Noriko Yamamoto; Eiji Shinoz 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 148 KB

Use of the folinic acid/5-fluorouracil/i

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB